Merck Q4 earnings in line with views

Merck's (MKGAF) Q4 EBITDA of $1.1B meets consensus estimate. Annual profit will be $4.45B slightly under the consensus target of $4.53B.

Q4 revenue fell 3.3% to $3.75B matching views.

The company is evaluating potential acquisitions as part of its plan to expand its footprint in the US, Japan and China.

This was corrected on 03/06/2014 at 08:51 AM.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs